Short-acting inhaled β2-agonists: why, whom, what, how?
- PMID: 33169817
- DOI: 10.5603/ARM.a2020.0132
Short-acting inhaled β2-agonists: why, whom, what, how?
Abstract
We showed the present data about the efficacy and safety of inhaled short-acting β2-agonists (SABA), such as salbutamol and fenoterol, in the management of obstructive diseases in children and adults. Our work discusses major mechanisms of action, clinical effects, possible side effects and indications of inhaled SABA. We presented current recommendations for the position of SABA in the therapy of obstructive diseases in children and adults, particularly in asthma and chronic obstructive pulmonary disease.
Keywords: COPD; asthma; fenoterol; inhalation; nebulization; salbutamol; short-acting β2-agonist.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical